248 results
Page 4 of 13
8-K
EX-2.1
5fao5i udz
30 Jul 19
Entry into a Material Definitive Agreement
5:07pm
425
EX-2.1
h2cl1735thaky7m
30 Jul 19
Business combination disclosure
5:06pm
425
ki66s1l3d wnqmx
30 Jul 19
Business combination disclosure
5:06pm
425
7iat k82w3
30 Jul 19
Business combination disclosure
12:00am
425
g22ytx
30 Jul 19
Business combination disclosure
12:00am
425
lnm 6tbbvrdlzrhpf0
30 Jul 19
Business combination disclosure
12:00am
425
90ht9mbo2xayylv4y9y
30 Jul 19
Business combination disclosure
12:00am
425
vae9afd
30 Jul 19
Business combination disclosure
12:00am
425
n5akrsoiracdxi7ymau7
30 Jul 19
Business combination disclosure
12:00am
8-K
EX-99
jfz7gxh2
29 Jul 19
Second-quarter revenue increased 94 percent to $200 million and Cologuard test volume increased 93 percent to 415,000
7:21am
425
EX-99
ywaauzf
29 Jul 19
Business combination disclosure
7:20am
8-K
EX-99.1
t6g6xtl k8gr7g8l
29 Jul 19
Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company
7:18am
425
EX-99.1
obr9 g376f0dcnk7ma
29 Jul 19
Business combination disclosure
7:16am
8-K
EX-1.1
rylv6ptmu7h5yq
8 Mar 19
Exact Sciences Announces Offering of $600 Million Convertible Senior Notes Due 2027
4:30pm